Worldwide Psoriasis Therapeutics Industry to 2028 – Players Include Astellas Pharma, AstraZeneca and GlaxoSmithKline – ResearchAndMarkets.com

Worldwide Psoriasis Therapeutics Industry to 2028 – Players Include Astellas Pharma, AstraZeneca and GlaxoSmithKline – ResearchAndMarkets.com




Worldwide Psoriasis Therapeutics Industry to 2028 – Players Include Astellas Pharma, AstraZeneca and GlaxoSmithKline – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Psoriasis Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028” report has been added to ResearchAndMarkets.com’s offering.

The report on the global psoriasis therapeutics market provides qualitative and quantitative analysis for the period from 2020 to 2028.

The report predicts the global psoriasis therapeutics market to grow with a CAGR of 9% over the forecast period from 2022-2028. The study on psoriasis therapeutics market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2020 to 2028.

The report on psoriasis therapeutics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global psoriasis therapeutics market over the period of 2020 to 2028. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter’s five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global psoriasis therapeutics market over the period of 2020 to 2028. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Market Dynamics

Drivers

  • Rising incidence of psoriasis with skin disorders
  • Increasing awareness among people

Restraints

  • High costs of therapies

Opportunities

  • Cumulative development of new biologics and new pipeline drugs

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the psoriasis therapeutics market.

2. Complete coverage of all the segments in the psoriasis therapeutics market to analyze the trends, developments in the global market and forecast of market size up to 2028.

3. Comprehensive analysis of the companies operating in the global psoriasis therapeutics market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Segments Covered

The global psoriasis therapeutics market is segmented on the basis of molecule type, route of administration, and dosage.

The Global Psoriasis Therapeutics Market by Molecule Type

  • Biologics
  • Small Molecules

The Global Psoriasis Therapeutics Market by Route Of Administration

  • Oral
  • Parenteral
  • Topical

The Global Psoriasis Therapeutics Market by Dosage

  • TNF Inhibitors
  • PDE4 Inhibitors
  • Interleukin Blockers
  • Others

Company Profiles

The companies covered in the report include:

  • Astellas Pharma Inc.
  • AstraZeneca plc
  • Boehringer Ingelheim GmbH
  • F. Hofffmann-La Roche
  • GlaxoSmithKline plc
  • Merck and Co., Inc.
  • Valeant Pharmaceuticals International, Inc.
  • Biocon Limited
  • Eli Lilly and Company
  • G and W Laboratories Inc.

For more information about this report visit https://www.researchandmarkets.com/r/r9vit4

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900